Profile data is unavailable for this security.
About the company
Sigyn Therapeutics, Inc. develops medical devices to treat cancer and infectious disease disorders. The Company's lead therapeutic candidate, Sigyn Therapy, is a broad-spectrum blood purification technology designed to treat pathogen-associated inflammatory disorders. Candidate treatment indications include endotoxemia and inflammation in end-stage renal disease (dialysis) patients, sepsis (a cause of hospital deaths), community-acquired pneumonia (a cause of death among infectious diseases), and emerging pandemic threats. Sigyn Therapy is a single-use disposable device that is deployable on the global infrastructure of hemodialysis and continuous renal replacement therapy machines. Its development pipeline includes a cancer treatment system comprised of ChemoPrep to enhance the tumor site delivery of chemotherapy, and ChemoPure to reduce treatment toxicity and inhibit the spread of cancer metastasis. Its ImmunePrep platform enhances the performance of immunotherapeutic antibodies.
- Revenue in USD (TTM)0.00
- Net income in USD-3.22m
- Incorporated2014
- Employees4.00
- LocationSigyn Therapeutics Inc9190 W Olympic Blvd # 263BEVERLY HILLS 90212United StatesUSA
- Phone+1 (619) 368-2000
- Fax+1 (845) 818-3588
- Websitehttps://www.sigyntherapeutics.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| LogicMark Inc | 10.61m | -9.87m | 616.12k | 31.00 | -- | 0.0298 | -- | 0.0581 | -1,486.41 | -1,486.41 | 27.80 | 25.56 | 0.5523 | 3.88 | 170.03 | 342,234.80 | -49.83 | -37.74 | -56.09 | -43.64 | 65.83 | 64.82 | -90.21 | -84.66 | 5.18 | -- | 0.00 | -- | -0.2784 | -10.39 | 41.04 | -- | 1.45 | -- |
| Nano Mobile Healthcare Inc | 0.00 | -5.46m | 654.75k | 3.00 | -- | -- | -- | -- | -0.2255 | -0.2255 | 0.00 | -0.0129 | 0.00 | -- | -- | 0.00 | -10,475.82 | -- | -- | -- | -- | -- | -- | -- | -- | -0.3173 | -- | -- | -- | -- | -- | -- | -- | -- |
| Nouveau Life Pharmaceuticals Inc | 0.00 | -504.00k | 666.10k | 0.00 | -- | 0.0113 | -- | -- | -0.0168 | -0.0168 | 0.00 | 0.0088 | 0.00 | -- | -- | -- | -39.38 | -- | -110.89 | -- | -- | -- | -- | -- | -- | -4.20 | 0.5507 | -- | -- | -- | -38.91 | -- | -- | -- |
| CYIOS Corp | 1.49m | -59.20k | 768.98k | 15.00 | -- | 0.2917 | -- | 0.515 | -0.0016 | -0.0016 | 0.0411 | 0.0086 | 3.51 | -- | 9.51 | 99,542.66 | -13.93 | -21.69 | -17.32 | -60.15 | 43.67 | 42.72 | -3.96 | -4.54 | -- | -- | 0.0867 | -- | 4.14 | 2.47 | 130.18 | -- | -- | -- |
| Medical Care Technologies Inc. | 0.00 | -1.07m | 821.00k | 0.00 | -- | -- | -- | -- | -553,570.10 | -553,570.10 | 0.00 | -389.23 | 0.00 | -- | -- | -- | -154.94 | -- | -- | -- | -- | -- | -- | -- | -- | -1.46 | -- | -- | -- | -- | -40.06 | -- | -- | -- |
| Venus Concept Inc | 58.88m | -54.61m | 892.38k | 292.00 | -- | 0.3339 | -- | 0.0152 | -46.93 | -46.93 | 48.24 | 1.44 | 0.8794 | 1.21 | 3.13 | 201,630.10 | -81.66 | -34.89 | -199.53 | -47.81 | 64.36 | 67.86 | -92.86 | -54.81 | 0.5934 | -6.68 | 0.9056 | -- | -15.09 | -10.10 | -26.16 | -- | -35.75 | -- |
| Zynex Inc | 108.20m | -73.96m | 972.44k | 1.00k | -- | -- | -- | 0.009 | -2.43 | -2.43 | 3.49 | -1.34 | 1.26 | 2.20 | 7.64 | 108,202.00 | -86.31 | 10.48 | -203.55 | 12.42 | 71.90 | 79.57 | -68.35 | 7.51 | 0.3174 | -12.22 | 3.19 | -- | 4.36 | 33.44 | -69.24 | -20.61 | 29.29 | -- |
| Leafbuyer Technologies Inc | 5.84m | 205.18k | 1.10m | 12.00 | 5.37 | -- | -- | 0.1886 | 0.002 | 0.002 | 0.0583 | -0.0142 | 6.35 | -- | 71.02 | 486,275.00 | 22.33 | -44.28 | -- | -- | 44.04 | 37.83 | 3.52 | -21.61 | -- | 3.07 | -- | -- | 15.54 | 20.68 | 136.74 | -27.51 | -- | -- |
| Sigyn Therapeutics Inc | 0.00 | -3.22m | 1.20m | 4.00 | -- | -- | -- | -- | -2.01 | -2.01 | 0.00 | -3.69 | 0.00 | -- | -- | 0.00 | -1,144.23 | -590.29 | -- | -- | -- | -- | -- | -- | -- | -3.44 | -- | -- | -- | -- | 19.43 | -- | -- | -- |
| Escalon Medical Corp | 11.94m | -200.38k | 1.28m | 39.00 | -- | 1.24 | -- | 0.1069 | -0.0436 | -0.0436 | 1.11 | 0.2259 | 2.57 | 3.67 | 7.31 | 306,156.90 | -2.20 | 1.53 | -4.99 | 3.48 | 45.38 | 43.87 | -0.8552 | 0.7026 | 0.979 | -1.96 | 0.1335 | -- | 0.5395 | 5.09 | 115.88 | -- | -42.12 | -- |
| Nu-Med Plus Inc | 0.00 | -54.13k | 1.28m | 2.00 | -- | -- | -- | -- | -0.0006 | -0.0006 | 0.00 | -0.0031 | 0.00 | -- | -- | 0.00 | -910.51 | -451.95 | -- | -- | -- | -- | -- | -- | -- | -8.61 | -- | -- | -- | -- | 45.55 | -- | -- | -- |
| Holder | Shares | % Held |
|---|---|---|
| Brio Capital Management LLCas of 31 Dec 2025 | 84.61k | 5.27% |
